Mepacrine Therapy in Niclosamide Resistant Taeniasis

Journal of Association of Physicians of India

Volumn 48, Issue 4, 2000, Pages 402-403

  Koul, P A ^a   Wahid, A ^a   Bhat, M H ^a   Wani, J I ^a   Sofi, B A ^a  

^a SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICESTODAL AGENT; MEPACRINE; NICLOSAMIDE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CYSTICERCOSIS; FEMALE; HUMAN; MALE; MIDDLE AGED; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTICESTODAL AGENTS; CHILD; CYSTICERCOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; NICLOSAMIDE; QUINACRINE; TREATMENT OUTCOME;

EID: 0034173443     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Perera DR, Western KA, Schultz MG. Niclosamide treatment of cestodiasis. Clinical trials in the United States. Am J Trop Med Hyg 1970; 19 : 610-2.
2. Gherman I. Observations on the treatment of taeniasis with niclosamide. Bull Soc Pathol Exot 1968; 61 : 432-4.
3. Pawlowski ZS. Cestodiasis: Taeniasis, Cysticercosis, Diphyllobothriasis and others. In: Warren KS, Mahmoud AAF, eds, Tropical and Geographical Medicine, 2nd ed, New York, McGraw Hill. 1990; 490-503.
4. Vermund SH, Macleod S, Goldstein RG. Taeniasis unresponsive to a single dose of niclosamide - case report of persistent infection with Taenia saginata and a review of therapy. Rev Infect Dis 1980; 8 : 423-6.
5. Koul PA, Wahid A, Wani JI, Sofi BA. Mepacrine therapy for niclosamide resistant taeniasis. (Abstract) Saudi J Gastroenterol 1996; 2 : 103-4.
6. O'Brien RL, Olenick JG, Hahn EE. Reactions of quinine, chloroquin and quinacrine with DNA and their effects on the DNA and RNA polymerase reactions. Proc Natl Acad Sci USA 1966; 55 : 1511-7.
7. Findlay GM. Recent advances in chemotherapy. London: J and A Churchill Ltd. 1951; 2.
8. Smith JW, Wolfe MS. Giardiasis. Annu Rev Med 1980; 31 : 373-83.
9. Lindenmayer JP, Vargas P. Toxic psychosis following use of quinacrine. J Clin Psychiatry 1981; 42 : 162-4.